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Edited by Barry HalliwellAbstract Chronic respiratory infections in cystic ﬁbrosis result
from CFTR channel mutations but how these impair antibacte-
rial defense is less clear. Airway host defense depends on lacto-
peroxidase (LPO) that requires thiocyanate (SCN) to
function and epithelia use CFTR to concentrate SCN at the
apical surface. To test whether CFTR mutations result in im-
paired LPO-mediated host defense, CF epithelial SCN trans-
port was measured. CF epithelia had signiﬁcantly lower
transport rates and did not accumulate SCN in the apical com-
partment. The lower CF [SCN] did not support LPO antibac-
terial activity. Modeling of airway LPO activity suggested that
reduced transport impairs LPO-mediated defense and cannot be
compensated by LPO or H2O2 upregulation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cystic ﬁbrosis (CF) is one of the most common genetic dis-
orders among Caucasians. The disease is characterized by
recurrent respiratory infections caused primarily by Staphylo-
coccus aureus and Pseudomonas aeruginosa [1]. Lifelong respi-
ratory infections result in progressive loss of lung function and
shortened life expectancy. Chronic infection implies failure of
airway host defenses against bacterial colonization. However,
the exact defects in CF host defense that are primarily respon-
sible for chronic infection in this disease remain unclear. The nor-
mal airway barrier to infection is complex and multifactorial.
One possible view is that mucus delays growth of pathogens
and attachment of bacteria and other particles to epithelia cells
until cilia mechanically clear them. The complex compositionAbbreviations: ALI, air–liquid interface; ASL, airway surface liquid;
CF, cystic ﬁbrosis; CFTR, cystic ﬁbrosis transmembrane regulator;
LPO, lactoperoxidase; MPO, myeloperoxidase
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doi:10.1016/j.febslet.2006.12.025of mucus must provide the proper viscoelastic properties to
permit ciliary clearance but also must contain broad-spectrum
antibiotic activities in order to be eﬀective.
Cystic ﬁbrosis transmembrane regulator (CFTR), the gene
product responsible for CF, contains an anion channel that
has been extensively characterized [2]. CFTR mutations result
in loss of functional anion channel activity on the apical cell
surface, although, it is not fully understood how a loss of anion
channel activity completely explains defective antibacterial de-
fenses. Several hypotheses have been proposed to relate these
two phenomena and focus on: (a) the eﬀects of airway surface
liquid (ASL) dehydration that leads to impaired ciliary and
cough clearance of mucus [3]; (b) the eﬀects of elevated ASL
salt concentration on the activity of antimicrobials in mucus
[4–6]; or (c) CFTR mediated defective bacterial–epithelial
interactions (for reviews see [7–11]).
Current views of CF pathogenesis may be limited by incom-
plete knowledge regarding the array of mechanisms at work in
airway defense. For example, the lactoperoxidase (LPO) sys-
tem has recently been shown to be present in airways, and to
be important for airway antibacterial activity and bacterial
clearance in both humans and sheep [12,13]. The LPO system
works to preserve sterility of secretions [14,15] in several spe-
cies including human. Similar to myeloperoxidase (MPO)
and eosinophil peroxidase (EPO), LPO uses H2O2 to catalyze
oxidation of the anion SCN to the antibiotic OSCN [16]
via an oxidized enzyme intermediate called compound I
(LPO-O)
H2O2 þ LPO! LPO-OþH2O
LPO-Oþ SCN ! OSCN þ LPO
Both SCN and H2O2 are required for LPO to function in the
airway lumen. Normal human airway epithelia transport
SCN from the basolateral to the apical surface and concen-
trate it in airway secretions [17]. This transport utilizes the so-
dium/iodide symporter at the basolateral surface to mediate
uptake of SCN or I into the cells followed by release to
the apical surface that is regulated by CFTR [17]. Normal
human airway epithelia also actively produce H2O2 at the
apical surface using Duox and release it into the apical surface
liquid [18]. This airway H2O2 production is increased through
stimulation of purinergic receptors [18] that also act to increase
mucus secretion [19,20] and ciliary beating [21–23] all through
intracellular Ca2+ increases. Thus, a complete antibacterialblished by Elsevier B.V. All rights reserved.
Table 1
Initial conditions for computations shown in Fig. 5 were derived from
estimates or measured amounts of enzyme and substrates [12],
transport rates (preliminary data, above), and volumes [3]
Normal CF Units
[H2O2] 0 0 M
[SCN] 4 · 104 1 · 104 M
[LPO] 7.2 · 108 14.4 · 108 M
SCN transport 1.04 · 106 0.263 · 106 M s1
H2O2 production 1 · 106 1 · 106 M s1
ASL volume (1 cm2) 2.5 · 106 1.25 · 106 l
Transport rates described in the text (shown in Fig. 1) are recalculated
to reﬂect the estimated ASL volume on 1 cm of epithelial surface. CF
LPO was increased 2-fold over normal to accommodate the reduced
ASL volume in CF.
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lated in concert with other facets of the airway host defense.
Since the LPO system is eﬀective against staphylococci [24],
E. coli and pseudomonads [24–26] and since SCN is a requi-
site substrate for LPO, defects in SCN transport and resulting
loss of LPO activity could contribute, at least partially, to the
chronic respiratory infections seen in CF patients. Although
MPO was previously thought to primarily use chloride as a
substrate, it is now recognized that MPO also uses SCN
and that SCN maybe the physiological substrate for MPO
[27]. In addition, hypochlorite (OCl), the product of MPO
oxidation of chloride, reacts almost instantaneously with
SCN at physiological concentrations [28] to give OSCN sug-
gesting that SCN may have a central role not only in LPO
antibacterial activity but also MPO antibacterial activity.
The described experiments test the hypothesis that CF air-
way epithelia are defective in SCN transport to the airway
surface and that this defect may be reﬂected by impaired or al-
tered peroxidase antibiotic activity in CF epithelial cell secre-
tions.2. Methods
2.1. Cell culture and thiocyanate transport experiments
Human airways were obtained following IRB approved protocols
from CF patients at the time of transplant or from organ donors whose
lungs were not used for transplant. Epithelial cells were isolated, grown
and diﬀerentiated on either 6.5 mm or 24 mm collagen-coated T-clear
membranes (Costar #3450) at an air–liquid interface as previously
described [29,30]. All experiments comparing non-CF and CF cells
were performed with cultures grown simultaneously and matched in
passage number, the number of cells plated, and days in culture. All
cultures had a resistivity P300 X cm. Prior to initiating experiments,
surfaces of air–liquid interface (ALI) cultures were washed with PBS,
returned to the air interface and incubated 18–24 h with 70 lM 14C-
SCN (50 lCi/mM) in the basolateral media. To start the experiments,
apical surfaces of the cultures were rapidly washed three times with
Dulbecco’s PBS (50 ll for 6.5 mm ﬁlters or 500 ll for 24 mm ﬁlters).
Following the third wash, additional aliquots were placed on the apical
surface for sequential 2 min incubations at 37 C in humidiﬁed 5%
CO2. Basolateral media were sampled after the last wash.
14C-SCN
in media and apical washes was determined by liquid scintillation
counting. All of the collected 14C-SCN was soluble following 10%
TCA precipitation showing that radiolabel was not covalently attached
to protein.
PKA stimulation was accomplished by adding 500 lM dibutyryl
cAMP and 10 lM forskolin to the PBS washes. To inhibit CFTR dur-
ing PKA stimulation, glibenclamide (500 lM) was added to washes
containing dibutyryl cAMP and forskolin.2.2. Assay of antibacterial activity
Antibacterial activity assays were performed essentially as described
previously [12]. Pseudomonas aeruginosa (ATCC 27853) were grown in
LB broth overnight, collected in the stationary phase, diluted to 5–
6 · 104/ml in LB broth with 15% glycerol and stored at 80 C. At
least 24 h prior to the experiments, basolateral media of matched
non-CF and CF ALI cultures (except controls) were supplemented
with 100 lM SCN. The apical surfaces of the cultures were washed
with 0.25 ml PBS and washes were pooled and stored at 20 C. SCN
dependent antibiotic activity was assayed using 560 ll of apical culture
washes, adjusted to pH 5.7, and containing 2400–3600 P. aeruginosa.
Since LPO was not secreted by the cells under these culture conditions,
washes were supplemented with 1.1 lg/ml LPO and 105 M H2O2.
Control experiments were performed in the absence of basolateral
addition of SCN or using only PBS never added to the cultures
and adjusted to pH 5.7. Growth of bacteria was not aﬀected by addi-
tion of 1.1 lg/ml LPO, 105 M H2O2, or 5 · 104 M SCN singly or
in pairs. However, addition of all three reconstituted a functionalLPO system that was bactericidal. To show SCN dependence, apical
CF culture washes were also supplemented to 5 · 104 M SCN in
some experiments. Mixtures were sampled immediately and 4 h after
incubation at room temperature and CFU were determined by plating
on LB Agar. Antibacterial activity was expressed as a ratio of CFU
after 4 h to the starting CFU in the sample to control for slight diﬀer-
ences in the starting number of bacteria.
2.3. Computational modeling of LPO activity
Diﬀerential equations describing LPO enzymatic activity were reiter-
atively integrated over 0.1 s intervals using IgorPro (WaveMetrics,
Portland, OR). Kinetic constants (k1 and k4) were those published
for human salivary lactoperoxidase [31] at pH 6.8 with the normal
steady state assumptions. Initial values for reactants, products and
LPO are shown in Table 1. The used equations were:
dH2O2=dt ¼ k1  ½H2O2  ½LPO þ k2 ð1Þ
dLPO=dt ¼ k1  ½H2O2  ½LPO  k4  ½LPO-O  ½SCN ð2Þ
dLPO-O=dt ¼ k1  ½H2O2  ½LPO  k4  ½LPO-O  ½SCN ð3Þ
dSCN=dt ¼ k4  ½LPO-O  ½SCN þ k3 ð4Þ
dOSCN=dt ¼ k4  ½LPO-O  ½SCN ð5Þ
where k2 and k3 are the H2O2 production rate and SCN
 transport
rates, respectively. The Igor Pro procedure code is available on request
to the authors.3. Results
3.1. Thiocyanate transport
We have previously shown that normal human bronchial
epithelial cells actively transport SCN from the basolateral
to apical surfaces and that the transport was regulated by
CFTR as it was stimulated by cAMP analogs and by forskolin,
and inhibited by apical glibenclamide, diphenylamine-2-carb-
oxylic acid and 5-nitro-2-(3-phenylpropylamino)-benzoate
[17]. Since a loss of SCN in the airway lumen might result
in a loss of LPO antibacterial activity and perhaps also aﬀect
neutrophil MPO antibacterial activity, we assessed whether
SCN transport was defective in CF bronchial epithelial cells
compared to normal epithelia. Airway epithelial cells, obtained
from CF lungs or non-CF lungs at the time of transplant or
organ donation, were passaged twice (thereby de-diﬀerenti-
ated) and then cultured at an air–liquid interface (ALI) for
re-diﬀerentiation [29,30]. As expected CF cell cultures showed
no change in short circuit current in Ussing chambers follow-
ing stimulation with forskolin.
To measure the transport of SCN across the epithelium,
14C-SCN was added to the basolateral media and, after over-
night incubation to allow an approach to steady state, its rate
Fig. 1. Thiocyanate transport in CF airway epithelium is defective. Panel a: 14C-SCN (70 lM) was added to the basolateral media of non-CF and
CF cultures for 18–24 h and stable unstimulated transport rates measured as described previously [17]. Non-CF cultures showed a 4-fold higher rate
of transport using 18 cultures from three non-CF and three CF individuals (n = 18, P < 0.0001). Panel b: 14C-SCN (70 lM) was added to the
basolateral media of cultures for 18–24 h. The 14C-SCN accumulated on the apical surface was collected in a PBS wash and measured by liquid
scintillation counting (n = 18 cultures each from three non-CF and three CF, P < 0.007).
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way epithelial cell cultures from three separate CF patients
were compared to non-CF control cultures from three individ-
uals. CF cells showed 4-fold reduced SCN transport rates
when compared to normal (CF, 2.3 ± 0.5 nmol/h/cm2 vs.
non-CF, 9.3 ± 1.7 nmol/h/cm2; n = 18; 3 donors, P < 0.0002,
one way ANOVA) (Fig. 1a). All three individuals had one
DF508 allele, one had a second W1282X allele (nonsense muta-
tion), while the second alleles in the other two patients were
unidentiﬁed. However, all were diagnosed with CF and
underwent lung transplant. Transport rates for cultures from
each CF individual were: D F508/W1282X, 1.69 ± 0.32
(n = 8) and 2.41 ± 0.72 (n = 5) as well as 3.65 ± 2.34 (n = 3)
for the other two. The diﬀerences in SCN transport between
non-CF and CF cultures were independent of the age of the
cultures (repeated measurements from 2 to 8-week-old cul-
tures), suggesting that a possible diﬀerence in time to reach full
diﬀerentiation between CF and non-CF cells was not responsi-
ble for these observations.
Exact determination of apical SCN concentration was not
possible in these experiments because the small apical surface
volumes naturally present on ALI cultures prevented accurate
sampling of CF cultures. However, comparison of the total
amounts of SCN, recovered in the initial 0.5 ml PBS wash
of the apical surface after overnight incubations with 14C-
SCN in the basolateral media, showed 11-fold higher levels
in non-CF compared to CF cultures (non-CF, 11.2 ±
3.0 nmol/cm2 vs. CF, 0.8 ± 0.2 nmol/cm2, n = 18, P < 0.0008,
one way ANOVA; Fig. 1b). Even though CF cultures are
reported to have about one half the amount of apical surface
ﬂuid when compared to non-CF [3], the diﬀerence in accumu-
lated apical 14C-SCN between CF and non-CF cultures
would remain signiﬁcant, even if this volume diﬀerence is taken
into account (5.5-fold). Thus, it appears that non-CF epithelial
layers accumulate SCN to signiﬁcantly higher levels than CF.
On the occasions when apical surface liquid was visible on
non-CF cultures that had been pre-incubated with basolateral
14C-SCN, direct sampling (2–5 ll) allowed measurement of
the [SCN] and showed that it was concentrated 6-fold over
the 0.07 mM in the basolateral media to 0.43 ± 0.13 mM,
n = 3. This concentration of SCN, measured in undiluted
non-CF apical surface liquid, is close to levels measured inundiluted airway secretions collected from patients, where we
measured 0.5 mM [12]. Liquid was never observed on the api-
cal surface of CF cultures, as expected from a previous report
[3] and therefore, direct measurement of [SCN] in CF apical
surface ﬂuid could not be made. However, by estimating the
values for CF cells using the diﬀerence to non-CF cells mea-
sured above (5.5-fold), the apical SCN concentration appears
likely to be close to that in the basolateral media (0.4 mM
divided by 5.5 would equal 0.072 mM).
Since previous studies showed that CFTR played a role in
SCN transport from the serosal to mucosal compartments
[17], we evaluated the possible contribution of CFTR anion
channel activity to the SCN transport observed in cultures.
Non-CF cultures showed the expected increase in SCN trans-
port after stimulation of PKA by apical addition of dibutyryl
cAMP (0.5 mM) and forskolin (10 lM), while CF cultures did
not (Fig. 2a–c). In non-CF airway epithelia, both the PKA-
stimulated and baseline SCN transport are completely and
reversibly blocked by glibenclamide [17]. Previous studies
showed that SCN transport in normal airway epithelia was
also sensitive to diphenylamine-2-carboxylic acid and 5-nitro-
2-(3-phenylpropylamino)-benzoate but not aﬀected by DIDS
and DNDS [17]. Thus, the lack of cAMP stimulated SCN
transport by CF epithelia is consistent with the idea that SCN
is delivered to the apical surface through CFTR.
3.2. Thiocyanate transport defects and in vitro antibacterial
activity
To assess the eﬀects of reduced SCN transport on LPO-
mediated antibacterial activity, the apical surfaces of cultures
were washed with PBS and these washes were used in antibac-
terial assays previously developed to assess LPO activity in
human tracheal secretions [12]. The day prior to washing,
SCN (100 lM) was added to the basolateral media of some
cultures to allow transport to the apical surface. Since culture
conditions did not result in LPO synthesis and secretion in
these ALI cultures, washes were supplemented with exogenous
bovine milk LPO and H2O2 (10
5 M). Supplementing washes
from cells, cultured in the absence of basolateral SCN, with
this concentration of H2O2 alone or in combination with
LPO did not give rise to any antibacterial activity (Fig. 3, com-
pare panel a and b). However, incubation of P. aeruginosa with
Fig. 2. PKA stimulation increases thiocyanate transport in non-CF but not in CF airway epithelia. To initiate the experiments, apical surfaces of the
cultures incubated overnight in 14C-SCN were rapidly washed three times. Additional PBS aliquots were placed on the apical surface for sequential
2 min washes and 14C-SCN was determined by liquid scintillation counting. cAMP stimulation of SCN eﬄux was demonstrated by adding
dibutyryl cAMP and forskolin to the PBS washes (18 min, indicated by the bar at top). The stimulated transport was inhibited by addition of
glibenclamide (28 min) to washes containing dibutyryl cAMP and forskolin. SCN ﬂux is expressed in nMoles of SCN/h normalized to 1 cm2 ﬁlter
area. In the CF culture, SCN transport was greatly diminished and not stimulated by cAMP. Bars at the top of graphs indicate the presence of PBS
alone, dibutyryl cAMP and forskolin (PKAst), or dibutyryl cAMP, forskolin and glibenclamide (Glib). Panels a–c show single experiments
comparing pairs of cultures obtained from three diﬀerent CF patients and three diﬀerent non-CF patients.
Fig. 3. Thiocyanate-mediated bacterial killing in ALI culture secre-
tions. Non-CF (solid bars, n = 6 cultures on separate days) and CF
(open bars, n = 4 cultures on separate days)ALI cultures were incubated
in the presence or absence of SCN in the basolateral media. Apical
surfaces were washed with PBS and combined for assay of antibacterial
activity as described in Section 2. Assays were performed with no
additions (panel a) or withLPOandH2O2 added to thewashes (panel b).
LPOandH2O2 did not increase the antibacterial activity of thewashes in
the absence of SCN, however in the presence of basolateral SCN
(panel c), only non-CF culture washes showed antibacterial activity.
Addition of SCN to washes of CF cultures restored the antibacterial
activity and increased the activity of non-CF culture washes (panel d).
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with basolateral SCN resulted in LPO-dependent killing of
bacteria (Fig. 3, panel c). In contrast, incubation of P. aerugin-
osa with LPO/H2O2 supplemented washes from CF cultures
grown with basolateral SCN had no detectable LPO-depen-
dent killing activity. Addition of exogenous SCN (0.5 mM)
to LPO/H2O2 supplemented culture washes generated antibac-
terial activity in CF samples grown with basolateral SCN,
demonstrating that the lack of antibacterial activity was the re-
sult of defective SCN transport by the CF epithelial cells (see
below). Addition of the same amount of SCN to the non-CF
culture washes grown with basolateral SCN increased the
LPO-dependent activity, already present, due to the further in-
crease in [SCN]. Thus, the lack of SCN transport by CF
cells compromised an in vitro LPO system reconstituted in
apical washes of the ALI cultures [32]. Although small num-bers of bacteria were used in the assays, substrates were not
replenished and were limiting.
3.3. Computational modeling of LPO activity in airway surface
liquid (ASL)
Since LPO activity depends on adequate [SCN], it is impor-
tant to understand whether lower LPO activity due to lower
[SCN], could be upregulated by compensatory changes in
enzyme concentration or H2O2 production. To visualize the
eﬀects of decreased [SCN] on LPO enzyme activity, we
estimated LPO activity as a function of [SCN] by calculating
reaction rates based on kinetic constants and the velocity equa-





þ ½SCNk1 þ Ki
½SCN2
k1
As expected, the lower SCN concentrations found in apical
CF culture washes resulted in lower enzymatic activity
(Fig. 4a and b). Interestingly, LPO has increased activity with
lower [SCN] at lower pH that might be encountered during
infection or with reduced bicarbonate transport seen in CF
(Fig. 4a and b). Increased initial LPO activity due to lower
initial pH resulted in more rapid depletion of SCN and was
not able to compensate for the loss of SCN transport (not
shown).
To approximate the eﬀects of lower SCN transport, diﬀer-
ential equations describing changes in reactants were used to
model LPO activity in ASL at pH 6.8. These computations al-
lowed assessment of the possible eﬀects of increasing [LPO]
and [H2O2] on LPO activity in an otherwise normal airway ex-
cept for a sharply reduced [SCN] transport as measured here
in CF airway epithelial cultures. The model used LPO kinetic
constants at pH 6.8 [31], the measured amounts of LPO in tra-
cheal secretions [12], the measured rates of SCN transport by
non-CF [17] and CF airway epithelia (above), as well as esti-
mates of ASL volume [3] per unit surface area. The concentra-
tion of H2O2 in ASL is not known. Therefore, initial values of
[H2O2] were set to zero and H2O2 production rates were set to
balance the transport of SCN and its consumption by LPO in
normal airways. The CF model utilized an ASL volume equal
to half that of the normal model [3] to account for a possible
Fig. 4. LPO activity varies with thiocyanate concentration and with pH. An arithmetic model of LPO activity using the kinetic constants published
by Pruitt et al. [31] calculated the expected LPO activity with [SCN] between 0.0001 M and 0.01 M (left panel) at pH 7.0, 6.5 and 6.0. The right panel
shows an expanded view between 0 and 0.5 mM (0.4 mM being the concentration found in human airway secretions).
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equivalent synthesis and secretion of LPO into this reduced
volume of ASL in CF, initial [LPO] was 2-fold normal in the
reduced transport (CF) model.
The simulation was carried out for 600 s. At 300 s, LPO was
increased 10-fold over the initial concentration in both the CF
and in the non-CF model to simulate possible compensatory
increases in enzyme concentration. Fig. 5 shows the calculated
concentrations of the substrates and the rate. Fig. 5a depicts
[SCN] changes in the normal and CF models. In the low
SCN transport CF model, SCN is rapidly consumed result-
ing in decreased rate of product formation (Fig. 5c) and a
corresponding increase in [H2O2] (Fig. 5b) as catalytic con-
sumption depletes SCN faster than it is replenished by dimin-
ished transport and thus, leading to decreased use of H2O2. To
demonstrate that an increase of LPO could not oﬀset the loss
of SCN transport, [LPO] was increased at 300 s, and only
resulted in a short transient increase in reaction velocity
(Fig. 5c).
Similar upregulation of H2O2 production did not restore
LPO activity in the CF model, however, increased H2O2 pro-
duction did stimulate LPO activity in the normal model until
[SCN] fell due to inability of SCN transport to sustain the
increased catalysis (not shown). Interestingly, increasing SCN
transport rate under normal conditions made little diﬀerence inFig. 5. Defective thiocyanate transport predicts a loss of LPO antibacterial a
surface liquid shows predicted changes in response to altered conditions in C
Initial conditions (shown in Table 1) were chosen based on published values, e
was set to balance SCN transport rates in normal cultures. Integration steps
conditions. Changes in [SCN], (panel a) and [H2O2], (panel b) include c
transport. Diﬀerentiation of OSCN product concentration with respect to t
level 10-fold higher than the initial [LPO] to mimic possible upregulation of th
a higher initial [LPO] to accommodate decreased CF ASL volume, comput
transport defect in CF. An increase in [LPO] (300 s) was unable to restore LP
predicts a loss of antibacterial activity in CF airways that cannot be compenLPO activity as the enzyme is nearly saturated with substrate
at normal transport rates. Computation using LPO rate con-
stants at pH 5.6 that could be encountered locally during infec-
tion accelerated the loss of SCN in the low transport CF
model. Thus, this computational model supports the idea that
the reduced [SCN] predicted by the above transport studies
cannot be compensated by upregulation of LPO or H2O2 or
changes in pH. The model also predicted that decreased SCN
transport may cause CF ASL to be deﬁcient in SCN render-
ing the LPO system unable to generate OSCN, therefore
impairing the antibacterial properties of mucus secretions.4. Discussion
The experiments presented here showed that CF airway
epithelia, cultured at the ALI, were defective in transporting
SCN from the basolateral to the apical compartment. The
absence of PKA stimulated SCN transport in CF cultures
is consistent with a role for CFTR in SCN transport sug-
gested by our previous studies [17]. The measured defect in
SCN transport by CF ALI cultures was reﬂected in a reduc-
tion of SCN accumulation on the apical surface and this
reduction resulted in a loss of reconstituted LPO antibacterial
activity that relied on substrate transported by the culturedctivity. Computational modeling of LPO enzymatic activity in airway
F airways, i.e. decreased volume and decreased SCN transport rates.
xcept [H2O2] that was arbitrarily set to zero. The H2O2 production rate
were 0.1 s. Shown are values of non-CF (solid line) and CF (dotted line)
onsumption by LPO catalysis and appearance due to production or
ime is shown in panel c. After 300 s, LPO concentration was reset to a
e enzyme concentration in response to lower SCN transport. Despite
ation showed that SCN could not be replaced fast enough given the
O reaction rate in CF due to faster consumption of SCN. The model
sated by increased LPO or H2O2.
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ported the concept that the eﬀect of the measured decrease in
SCN transport on LPO enzymatic activity could not be com-
pensated by upregulating either LPO or H2O2 and thus pre-
dicted a loss of LPO-mediated host defense in CF airways. If
the measured diﬀerence in apical SCN between CF and
non-CF airway epithelial cells is reﬂected in vivo, it is likely
to be functionally signiﬁcant since OSCN production by
LPO at the relevant SCN concentrations are signiﬁcantly dif-
ferent [33] and bacterial growth in vitro is inversely propor-
tional to the [OSCN] [34]. Although certain changes in CF
epithelial phenotype in culture have been noted by others,
these changes were seen in primary cultures and disappeared
after 6–11 days in culture [35]. Our re-diﬀerentiated cultures
(passaged once) have been in culture for much longer and
are not expected to exhibit these changes noted in primary cul-
tures.
Exact determination of SCN concentration in normal and
CF airway secretions is not currently possible. Thiocyanate
content in normal secretions is near the limit of detection of
colorimetric assays [12] and dilutions associated with broncho-
alveolar lavage will require development of more sensitive
methods. Our model predicted complete depletion of SCN
in CF secretions and the presence of large amounts of MPO
due to chronic infection of CF airways virtually assures no
SCN to be measurable in secretions. Thus, accurate compar-
ison of SCN levels in CF and normal airways will require
development of a highly sensitive assay method and will be
best done in patients early in life prior to establishment of
chronic infection and neutrophilic inﬂammation.
In lieu of direct measurement of ASL [SCN], the computa-
tional model presented here predicted that decreased SCN
transport of the magnitude measured results in complete deple-
tion of this LPO substrate and that upregulation of LPO
enzyme activity cannot compensate for lower SCN transport
measured in the in vitro system. The model also suggested that
H2O2 normally produced by airway epithelia [18,36,37] and
consumed by LPO [38] will increase if SCN transport is not
able to provide suﬃcient substrate and might perhaps lead to
increased oxidative damage in the CF airway. Thus, the model
predicted that changes in the LPO and H2O2 concentrations in
CF ASL cannot oﬀset the measured loss of SCN transport.
It is important to note that the computational model used
empirically determined rate constants for puriﬁed human
LPO from saliva and thus the model does not take into
account the presence of other components normally found in
normal and CF airways. The model therefore cannot accu-
rately predict the eﬀects of other potential antibacterial perox-
idase substrates such as nitrite. Nor does the model take into
account the formation of LPO compound II that can generate
SCN radicals and is now thought to be an important part of
the normal peroxidase catalytic cycle [39]. The model also does
not address MPO activities and cannot predict a complete loss
of peroxidase mediated antibacterial activity but instead pri-
marily serves to predict that upregulation of LPO expression
cannot compensate for the observed reduction in SCN trans-
port.
Although most studies of MPO-mediated bacterial killing
have concentrated on its use of Cl, SCN has recently been
shown to be the preferred substrate of MPO [27,40] and nor-
mally OCl immediately reacts with SCN to produce OSCN
[28]. The presence of high levels of MPO in CF airways, thatalso consumes SCN (e.g. [27]), virtually ensures the full con-
sumption of SCN in the presence of an impaired transport
system and suggests an increased use of chloride as a substrate
and generation of OCl. Since OCl is believed to very rapidly
react with SCN in physiological conditions, increased pro-
duction of OCl that might also contribute to increased oxida-
tive damage in the airway. Although hypochlorite itself is a
potent antibacterial, CF airway secretions are reported to have
high levels of taurine (>3 mM) [41] that reacts extremely
rapidly with hypochlorite and thus is expected to buﬀer the
antibacterial eﬀects [42,43]. Nevertheless mono and dichlorota-
urine are also antibacterial, although much less so than HOCl
[44,45]. The mechanisms by with chlorotaurines are antibacte-
rial are not known. Clearly, a full understanding of the eﬀects
of SCN transport changes in CF airways will require more
investigation including studies of the phenotypic changes in
bacteria that occur after chronic colonization. Thus, impaired
SCN transport to the airway lumen could potentially cause
signiﬁcant alteration of both the epithelial-derived LPO system
as well as the neutrophil-derived MPO antibacterial activity.
The SCN permeability and conductance of the CFTR
anion channel is known (e.g. [46–48]) and suggested that a
SCN transport deﬁciency might be relevant to increased
infection in CF. Our previous studies on SCN transport by
airway epithelia support a role for CFTR in SCN transport
[17] and the decreased SCN transport and lack of PKA stim-
ulation in the CF cultures shown here are also consistent with
a role for CFTR. We have not ruled out the possibility that
NaI symporter in the basolateral membrane is also reduced
in CF although such a reduction is not expected to be relevant
in the absence of functional CFTR.
Since LPO has antimicrobial activity against a broad spec-
trum of pathogens including respiratory pathogens relevant
in CF (e.g. [12]), a CFTR dependent defect in LPO-mediated
host defense might be relevant to cystic ﬁbrosis. In our studies
shown here, and in previous studies [12], small numbers of bac-
teria were used in an in vitro system that was not replenished
with either SCN or H2O2 during the assay. In vivo, continu-
ous production of H2O2 [18,36,49] and SCN
 transport in the
presence of LPO are expected to continuously produce larger
quantities of OSCN for antibacterial host defense that are
expected to prevent colonization of the airway but may not
be able to eradicate an established infection.
There may be several reasons that the role of LPO in airway
host defense, and a possible loss of its activity due to the anion
transport defect in CF, have not previously attracted attention.
First, studies that focus on antibacterial activity of airway
secretions do not typically detect LPO activity since LPO
requires H2O2 as a substrate and H2O2 is rapidly consumed
and not present in secretions after collection and storage
[38]. Thus, to detect LPO activity requires replenishing secre-
tions with the estimated low physiological [H2O2] something
not generally added in studies of antibacterial activity in air-
way secretions (e.g. [50]). These levels of H2O2, added to
in vitro peroxidase antibacterial systems, are well below the
levels needed for killing of bacteria by H2O2 alone (e.g. [12]).
Second, broad screens of antibacterial substances have often
focused on components with molecular masses below that of
LPO (e.g. [51]). Finally LPO has an acidic pH optimum
(pH 5.5) and shows reduced activity above pH 7.0. Thus,
LPO’s characteristics and substrate needs may have slowed
appreciation of its role in airway host defense.
G.E. Conner et al. / FEBS Letters 581 (2007) 271–278 277Chronic infection in CF appears to arise from multiple
defects in airway host defense. For example, inadequate ASL
leads to dehydrated mucus, reduced mucociliary clearance
[3], and decreased neutrophil migration into mucus [52]. Since
LPO appears to be constitutively present in normal airway
secretions, loss of its activity due to a SCN transport defect
may be an additional defect in CF airway host defense. Thus
the data presented here support further studies of SCN levels
in CF airways.
Acknowledgements: We thank Dr. Adam Wanner for his thoughtful
advice and strong support throughout this work. This work also
acknowledges the memory of James R. Haft M.D. who inspired us
by his lifelong determination and his dedication to medicine before
his death from cystic ﬁbrosis. This work was supported in part by
the grants from NHLBI (G.E.C. and M.S.) and The Cystic Fibrosis
Foundation (S.H.R.). Correspondence and requests for materials
should be addressed to G.E.C.References
[1] Boat, T.F. and Boucher, R.C. (1994) (Murray, J.F. and Nadel,
J.A., Eds.), Textbook of Respiratory Medicine, Vol. 2, pp. 1418–
1450, W.B. Saunders Co., Philadelphia.
[2] Sheppard, D.N. and Welsh, M.J. (1999) Structure and function of
the CFTR chloride channel. Physiol. Rev. 79, S23–S45.
[3] Matsui, H., Grubb, B.R., Tarran, R., Randell, S.H., Gatzy, J.T.,
Davis, C.W. and Boucher, R.C. (1998) Evidence for periciliary
liquid layer depletion, not abnormal ion composition, in the
pathogenesis of cystic ﬁbrosis airways disease. Cell 95, 1005–1015.
[4] Smith, J.J., Travis, S.M., Greenberg, E.P. and Welsh, M.J. (1996)
Cystic ﬁbrosis airway epithelia fail to kill bacteria because of
abnormal airway surface ﬂuid. Cell 85, 229–236.
[5] Zabner, J., Smith, J.J., Karp, P.H., Widdicombe, J.H. and Welsh,
M.J. (1998) Loss of CFTR chloride channels alters salt absorption
by cystic ﬁbrosis airway epithelia in vitro. Mol. Cell 2, 397–
403.
[6] Goldman, M.J., Anderson, G.M., Stolzenberg, E.D., Kari, U.P.,
Zasloﬀ, M. and Wilson, J.M. (1997) Human beta-defensin-1 is a
salt-sensitive antibiotic in lung that is inactivated in cystic ﬁbrosis.
Cell 88, 553–560.
[7] Wine, J.J. (1999) The genesis of cystic ﬁbrosis lung disease. J. Clin.
Invest. 103, 309–312.
[8] Travis, S.M., Singh, P.K. and Welsh, M.J. (2001) Antimicrobial
peptides and proteins in the innate defense of the airway surface.
Curr. Opin. Immunol. 13, 89–95.
[9] Bals, R., Weiner, D.J. and Wilson, J.M. (1999) The innate
immune system in cystic ﬁbrosis lung disease. J. Clin. Invest. 103,
303–307.
[10] Guggino, W.B. (1999) Cystic ﬁbrosis and the salt controversy.
Cell 96, 607–610.
[11] Goldberg, J.B. and Pier, G.B. (2000) The role of the CFTR in
susceptibility to Pseudomonas aeruginosa infections in cystic
ﬁbrosis. Trends Microbiol. 8, 514–520.
[12] Wijkstrom-Frei, C., El-Chemaly, S., Ali-Rachedi, R., Gerson, C.,
Cobas, M.A., Forteza, R., Salathe, M. and Conner, G.E. (2003)
Lactoperoxidase and human airway host defense. Am. J. Respir.
Cell Mol. Biol. 29, 206–212.
[13] Gerson, C. et al. (2000) The lactoperoxidase system functions in
bacterial clearance of airways. Am. J. Respir. Cell Mol. Biol. 22,
665–671.
[14] Reiter, N. and Perraudin, J.P. (1991) (Everse, J., Everse, K.E. and
Grisham, M.B., Eds.), Peroxidases in Chemistry and Biology,
Vol. I, pp. 143–180, CRC Press, Boca Raton, FL.
[15] Pruitt, K.M. (1987) The salivary peroxidase system: thermody-
namic, kinetic and antibacterial properties. J. Oral Pathol. 16,
417–420.
[16] Thomas, E.L., Bozeman, P.M. and Learn, D.B. (1991) in:
Peroxidases in Chemistry and Biology (Everse, J., Everse, K.E.
and Grisham, M.B., Eds.), pp. 123–142, CRC Press, Boca Raton,
FL.[17] Fragoso, M.A., Fernandez, V., Forteza, R., Randell, S.H.,
Salathe, M. and Conner, G.E. (2004) Transcellular thiocyanate
transport by human airway epithelia. J. Physiol. 561, 183–194.
[18] Forteza, R., Salathe, M., Miot, F., Forteza, R. and Conner, G.E.
(2005) Regulated hydrogen peroxide production by Duox in
human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 32,
462–469.
[19] Davis, C.W., Dowell, M.L., Lethem, M. and Van Scott, M. (1992)
Goblet cell degranulation in isolated canine tracheal epithelium:
response to exogenous ATP, ADP, and adenosine. Am. J. Physiol.
262, C1313–C1323.
[20] Kim, K.C. and Lee, B.C. (1991) P2 purinoceptor regulation of
mucin release by airway goblet cells in primary culture. Br. J.
Pharmacol. 103, 1053–1056.
[21] Saano, V., Virta, P., Joki, S., Nuutinen, J., Karttunen, P. and
Silvasti, M. (1992) ATP induces respiratory ciliostimulation in rat
and guinea pig in vitro and in vivo. Rhinology 30, 33–40.
[22] Wong, L.B. and Yeates, D.B. (1992) Luminal purinergic regula-
tory mechanisms of tracheal ciliary beat frequency. Am. J. Respir.
Cell Mol. Biol. 7, 447–454.
[23] Villalon, M., Hinds, T.R. and Verdugo, P. (1989) Stimulus-
response coupling in mammalian ciliated cells. Demonstration of
two mechanisms of control for cytosolic [Ca2+]. Biophys. J. 56,
1255–1258.
[24] Johansen, C., Falholt, P. and Gram, L. (1997) Enzymatic removal
and disinfection of bacterial bioﬁlms. Appl. Environ. Microbiol.
63, 3724–3728.
[25] Bjorck, L., Rosen, C., Marshall, V. and Reiter, B. (1975)
Antibacterial activity of the lactoperoxidase system in milk
against pseudomonads and other gram-negative bacteria. Appl.
Microbiol. 30, 199–204.
[26] Reiter, B., Marshall, V.M., Bjorck, L. and Rosen, C.G. (1976)
Nonspeciﬁc bactericidal activity of the lactoperoxidases-thiocya-
nate- hydrogen peroxide system of milk against Escherichia
coli and some gram-negative pathogens. Infect. Immun. 13, 800–
807.
[27] van Dalen, C.J., Whitehouse, M.W., Winterbourn, C.C. and
Kettle, A.J. (1997) Thiocyanate and chloride as competing
substrates for myeloperoxidase. Biochem. J. 327, 487–492.
[28] Ashby, M.T., Carlson, A.C. and Scott, M.J. (2004) Redox
buﬀering of hypochlorous acid by thiocyanate in physiologic
ﬂuids. J. Am. Chem. Soc. 126, 15976–15977.
[29] Nlend, M.C., Bookman, R.J., Conner, G.E. and Salathe, M.
(2002) Regulator of G-protein signaling protein 2 modulates
purinergic calcium and ciliary beat frequency responses in airway
epithelia. Am. J. Respir. Cell Mol. Biol. 27, 436–445.
[30] Fulcher, M.L., Gabriel, S., Burns, K.A., Yankaskas, J.R. and
Randell, S.H. (2005) Well-diﬀerentiated human airway epithelial
cell cultures. Methods Mol. Med. 107, 183–206.
[31] Pruitt, K.M., Mansson-Rahemtulla, B., Baldone, D.C. and
Rahemtulla, F. (1988) Steady-state kinetics of thiocyanate oxida-
tion catalyzed by human salivary peroxidase. Biochemistry 27,
240–245.
[32] Mansson-Rahemtulla, B., Rahemtulla, F., Baldone, D.C., Pruitt,
K.M. and Hjerpe, A. (1988) Puriﬁcation and characterization of
human salivary peroxidase. Biochemistry 27, 233–239.
[33] Pruitt, K.M., Mansson-Rahemtulla, B. and Tenovuo, J. (1983)
Detection of the hypothiocyanite (OSCN) ion in human parotid
saliva and the eﬀect of pH on OSCN generation in the
salivary peroxidase antimicrobial system. Arch. Oral Biol. 28,
517–525.
[34] Tenovuo, J., Makinen, K.K. and Sievers, G. (1985) Antibacterial
eﬀect of lactoperoxidase and myeloperoxidase against Bacillus
cereus. Antimicrob. Agents Chemother. 27, 96–101.
[35] Ribeiro, C.M., Paradiso, A.M., Schwab, U., Perez-Vilar, J.,
Jones, L., O’Neal, W. and Boucher, R.C. (2005) Chronic airway
infection/inﬂammation induces a Ca2þi -dependent hyperinﬂam-
matory response in human cystic ﬁbrosis airway epithelia. J. Biol.
Chem. 280, 17798–17806.
[36] Geiszt, M., Witta, J., Baﬃ, J., Lekstrom, K. and Leto, T.L. (2003)
Dual oxidases represent novel hydrogen peroxide sources sup-
porting mucosal surface host defense. Faseb J. 17, 1502–1504.
[37] Schwarzer, C., Machen, T.E., Illek, B. and Fischer, H. (2004)
NADPH oxidase-dependent acid production in airway epithelial
cells. J. Biol. Chem. 279, 36454–36461.
278 G.E. Conner et al. / FEBS Letters 581 (2007) 271–278[38] El-Chemaly, S., Salathe, M., Baier, S., Conner, G.E. and Forteza,
R. (2003) Hydrogen peroxide-scavenging properties of normal
human airway secretions. Am. J. Respir. Crit. Care Med. 167,
425–430.
[39] Tahboub, Y.R., Galijasevic, S., Diamond, M.P. and Abu-Soud,
H.M. (2005) Thiocyanate modulates the catalytic activity of
mammalian peroxidases. J. Biol. Chem. 280, 26129–26136.
[40] Furtmuller, P.G., Burner, U. and Obinger, C. (1998) Reaction of
myeloperoxidase compound I with chloride, bromide, iodide, and
thiocyanate. Biochemistry 37, 17923–17930.
[41] Cantin, A.M. (1994) Taurine modulation of hypochlorous acid-
induced lung epithelial cell injury in vitro. Role of anion
transport. J. Clin. Invest. 93, 606–614.
[42] Thomas, E.L., Grisham, M.B. and Jeﬀerson, M.M. (1986)
Preparation and characterization of chloramines. Methods Enz-
ymol. 132, 569–585.
[43] Thomas, E.L., Grisham, M.B. and Jeﬀerson, M.M. (1986)
Cytotoxicity of chloramines. Methods Enzymol. 132, 585–593.
[44] Grisham, M.B., Jeﬀerson, M.M., Melton, D.F. and Thomas, E.L.
(1984) Chlorination of endogenous amines by isolated neutro-
phils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic
activities of the chloramines. J. Biol. Chem. 259, 10404–10413.
[45] Thomas, E.L. (1979) Myeloperoxidase, hydrogen peroxide, chlo-
ride antimicrobial system: nitrogen-chlorine derivatives of bacte-
rial components in bactericidal action against Escherichia coli.
Infect. Immun. 23, 522–531.[46] Illek, B., Tam, A.W., Fischer, H. and Machen, T.E. (1999) Anion
selectivity of apical membrane conductance of Calu 3 human
airway epithelium. Pﬂugers Archiv – Eur. J. Physiol. 437, 812–
822.
[47] Hipper, A., Mall, M., Greger, R. and Kunzelmann, K. (1995)
Mutations in the putative pore-forming domain of CFTR do not
change anion selectivity of the cAMP activated Cl-conductance.
FEBS Lett. 374, 312–316.
[48] Tabcharani, J.A., Rommens, J.M., Hou, Y.X., Chang, X.B., Tsui,
L.C., Riordan, J.R. and Hanrahan, J.W. (1993) Multi-ion pore
behaviour in the CFTR chloride channel. Nature 366, 79–82, [see
comments].
[49] Ali-Rachedi, R., Gelin, M., Forteza, R. and Conner, G.E. (2003)
Hydrogen peroxide production in airway epithelial cells is
catalyzed by Gp91phox homologs highly similar to Duox 1.
Am. J. Respir. Crit. Care Med. 167, A284.
[50] Dajani, R. et al. (2005) Lysozyme secretion by submucosal glands
protects the airway from bacterial infection. Am. J. Respir. Cell
Mol. Biol. 32, 548–552.
[51] Cole, A.M., Dewan, P. and Ganz, T. (1999) Innate antimicrobial
activity of nasal secretions. Infect. Immun. 67, 3267–3275.
[52] Matsui, H., Verghese, M.W., Kesimer, M., Schwab, U.E.,
Randell, S.H., Sheehan, J.K., Grubb, B.R. and Boucher, R.C.
(2005) Reduced three-dimensional motility in dehydrated airway
mucus prevents neutrophil capture and killing bacteria on airway
epithelial surfaces. J. Immunol. 175, 1090–1099.
